(Hypertension. 1996;27:774-780.)
© 1996 American Heart Association, Inc.
Articles |
From the Centre de Recherche Hôtel-Dieu de Montréal, Université de Montréal (Québec), Canada.
Correspondence to Pavel Hamet, MD, PhD, Laboratory of Molecular Pathophysiology, Centre de Recherche Hôtel-Dieu de Montréal, 3850 St. Urbain St, Montréal, Québec H2W 1T8, Canada.
Abstract This study examines the role of the cAMP signaling pathway in the regulation of 45Ca influx in cultured vascular smooth muscle cells from the rat aorta. K+o-induced depolarization of smooth muscle cells increased the rate of 45Ca uptake by twofold to threefold. This effect was completely abolished by the dihydropyridine derivatives nifedipine and nicardipine, with a Ki of 3 and 10 nmol/L, respectively. Activators of cAMP signaling (isoproterenol, forskolin, cholera toxin) increased cAMP content by 50- to 100-fold and decreased voltage-dependent 45Ca uptake by 50% to 70%. Neither the dihydropyridines nor the cAMP activators affected basal 45Ca influx. Direct addition of the protein kinase inhibitor H-89 to the incubation medium in the 1- to 10-µmol/L range did not alter basal 45Ca uptake but completely abolished voltage-dependent Ca2+ transport. Preincubation of cells for 1 hour with 10 µmol/L H-89 did not modify basal and depolarization-induced 45Ca uptake in H-89free medium but prevented forskolin-induced inhibition of voltage-dependent Ca2+ influx. The addition of cytoskeleton-active compounds reduced voltage-dependent Ca2+ transport and completely abolished its regulation by cAMP. Activation of cAMP signaling decreased the volume of smooth muscle cells by 12% to 15%. The same cell volume diminution in hyperosmotic medium did not alter voltage-dependent 45Ca uptake. Thus, data obtained in this study show that in contrast to cardiac and skeletal myocytes, in vascular smooth muscle cells, 45Ca influx, putatively due to L-type channels, is inhibited by cAMP. This regulatory pathway appears to be mediated via protein kinase A activation and cytoskeleton reorganization.
Key Words: muscle, smooth, vascular calcium channels cyclic AMP cytoskeleton
This article has been cited by other articles:
![]() |
M Hennenberg, J Trebicka, T Sauerbruch, and J Heller Mechanisms of extrahepatic vasodilation in portal hypertension Gut, September 1, 2008; 57(9): 1300 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Zhang, Y. Shirasawa, X. Chen, H. Yu, and J. N. Benoit Impaired agonist-dependent myosin phosphorylation and decreased RhoA in rat portal hypertensive mesenteric vasculature Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G603 - G608. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Gosmanov, Z. Fan, X. Mi, E. G. Schneider, and D. B. Thomason ATP-sensitive potassium channels mediate hyperosmotic stimulation of NKCC in slow-twitch muscle Am J Physiol Cell Physiol, March 1, 2004; 286(3): C586 - C595. [Abstract] [Full Text] |
||||
![]() |
S. Taurin, N. O Dulin, D. Pchejetski, R. Grygorczyk, J. Tremblay, P. Hamet, and S. N Orlov c-Fos expression in ouabain-treated vascular smooth muscle cells from rat aorta: evidence for an intracellular-sodium-mediated, calcium-independent mechanism J. Physiol., September 15, 2002; 543(3): 835 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. PURDY and W. J. ARENDSHORST Iloprost Inhibits Inositol-1,4,5-Trisphosphate-Mediated Calcium Mobilization Stimulated by Angiotensin II in Cultured Preglomerular Vascular Smooth Muscle Cells J. Am. Soc. Nephrol., January 1, 2001; 12(1): 19 - 28. [Abstract] [Full Text] |
||||
![]() |
K. L. Dodge, D. W. Carr, and B. M. Sanborn Protein Kinase A Anchoring to the Myometrial Plasma Membrane Is Required for Cyclic Adenosine 3',5'-Monophosphate Regulation of Phosphatidylinositide Turnover Endocrinology, November 1, 1999; 140(11): 5165 - 5170. [Abstract] [Full Text] |
||||
![]() |
M. S. Taylor and J. N. Benoit Effect of milrinone on small mesenteric artery vasoconstriction: role of K+ channels Am J Physiol Gastrointest Liver Physiol, July 1, 1999; 277(1): G69 - G78. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. STOCKAND and S. C. SANSOM Glomerular Mesangial Cells: Electrophysiology and Regulation of Contraction Physiol Rev, July 1, 1998; 78(3): 723 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Uhlig, R. L. Featherstone, H.-D. Held, R. Nüsing, C. Schudt, and A. Wendel Attenuation by Phosphodiesterase Inhibitors of Lipopolysaccharide-Induced Thromboxane Release and Bronchoconstriction in Rat Lungs J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1453 - 1459. [Abstract] [Full Text] |
||||
![]() |
N. O. Dulin, J. Niu, D. D. Browning, R. D. Ye, and T. Voyno-Yasenetskaya Cyclic AMP-independent Activation of Protein Kinase A by Vasoactive Peptides J. Biol. Chem., June 8, 2001; 276(24): 20827 - 20830. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |